Medicine
Likmez 100 mg/mL oral suspension
Likmez 100 mg/mL oral suspension is a prescription medicine containing Metronidazole for oral use, marketed by Saptalis Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store between 20°C to 25°C (68°F to 77°F). Brief exposure to…
Key facts
- Active ingredient (INN)
- Metronidazole
- Brand
- Likmez
- Strength
- 100 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 200 mL, 75 mL
- Marketing authorisation holder
- Saptalis Pharmaceuticals
- Manufacturers
- Saptalis PharmaceuticalsKesin Pharma
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store between 20°C to 25°C (68°F to 77°F). Brief exposure to 15°C to 30°C (59°F to 86°F) permitted.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AB17 Metronidazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 October 2023
- Identifiers
- RxCUI 2667642, 2667648DailyMed set ID 23927a8b-1641-4104-aa85-d7b7bf4ebb9d, e20c14eb-5361-4a93-ab46-a7bd9aeb9b98NDC 81033-066, 71656-066Application NDA216755
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 200 mL in 1 bottle | 71656-066-20 | Saptalis Pharmaceuticals | 13 October 2023 |
| 75 mL in 1 bottle | 71656-066-75 | Saptalis Pharmaceuticals | 22 July 2024 |
| 200 mL in 1 bottle | 81033-066-20 | Kesin Pharma | 13 October 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 July 1963 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Metronidazole
Clinical summary
Metronidazole is a nitroimidazole antimicrobial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria, among other approved uses. It is available as tablets, vaginal gel and gel for oral and topical use. MedsAcross supplies Metronidazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MetronidazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Metronidazole prescribing information (Civica) · U.S. National Library of Medicine, DailyMed
Need Likmez 100 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.